Delivery Order SPE2DR25D1002-SPE2DR26FGL4S
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,746.14 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count packaging) with a completion date of November 10, 2025. This non-competitive, firm fixed-price delivery order was issued on November 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is well-positioned to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,414.80 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count packages). This firm fixed-price, non-set-aside delivery order was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued under a larger indefinite delivery contract...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count) under a firm fixed-price contract. The order, valued at $1,477.66, was competitively awarded without a set-aside designation and carries an ultimate completion date of December 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,986.03 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count supply). This firm fixed-price, non-set-aside contract was awarded on November 17, 2025, with an ultimate completion date of November 18, 2025. The award represents a direct delivery order against AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of...
- The Defense Logistics Agency awarded a delivery order valued at $1,986.42 to AmerisourceBergen Drug Corp for 30-count bottles of Veozah 45 mg tablets, with performance completion scheduled for November 4, 2025. This firm fixed-price delivery order, issued on November 3, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Veozah 45 mg tablets (30-count units) with a ceiling value of $11,894.89. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count units) with a ceiling value of $16,639.53. This firm fixed-price delivery order was issued on November 7, 2025, with an ultimate completion date of November 10, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $1,470.52 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-unit supply), with an ultimate completion date of July 25, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a delivery order valued at $4,797.71 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count units) on December 16, 2025, with an ultimate completion date of December 17, 2025. This non-set-aside contract utilizes firm fixed price terms and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,930.10 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count units) on October 14, 2025, with an ultimate completion date of October 15, 2025. This firm fixed-price, competitively awarded delivery order represents fulfillment under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGL4SDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,829.44 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count unit) with a firm fixed price and an ultimate completion date of December 17, 2025. This non-set-aside, competitively awarded delivery order was issued on December 16, 2025, with performance of work to be conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this requirement under its existing indefinite delivery contract with DLA Troop Support Medical. This delivery order represents a routine pharmaceutical procurement through AmerisourceBergen's SPE2DX indefinite delivery contract, valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The DLA Troop Support Medical utilizes this prime contract to source brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's consistent success in winning competitive federal pharmaceutical awards demonstrates its capability to meet stringent procurement requirements and support the DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/15/25 |